Prion-Like Characteristics of Polyglutamine-Containing Proteins

被引:38
|
作者
Pearce, Margaret M. P. [1 ]
Kopito, Ron R. [2 ]
机构
[1] Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA
[2] Stanford Univ, Dept Biol, Stanford, CA 94305 USA
来源
关键词
AGE-OF-ONSET; INCLUSION-BODY FORMATION; MUTANT-HUNTINGTIN; ALPHA-SYNUCLEIN; NUCLEAR-LOCALIZATION; TRINUCLEOTIDE REPEAT; DROSOPHILA MODEL; CAG-REPEAT; CELL-DEATH; IN-VITRO;
D O I
10.1101/cshperspect.a024257
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Transmissible spongiform encephalopathies are infectious neurodegenerative diseases caused by the conversion of prion protein (PrP) into a self-replicating conformation that spreads via templated conversion of natively folded PrP molecules within or between cells. Recent studies provide compelling evidence that prion-like behavior is a general property of most protein aggregates associated with neurodegenerative diseases. Many of these disorders are associated with spontaneous protein aggregation, but genetic mutations can increase the aggregation propensity of specific proteins, including expansion of polyglutamine (polyQ) tracts, which is causative of nine inherited neurodegenerative diseases. Aggregates formed by polyQ-expanded huntingtin (Htt) in Huntington's disease can transfer between cells and seed the aggregation of cytoplasmic wild-type Htt in a prion-like manner. Additionally, prion-like properties of glutamine-rich proteins underlie nonpathological processes in yeast and higher eukaryotes. Here, we review current evidence supporting prion-like characteristics of polyQ and glutamine-rich proteins.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Polyglutamine-containing proteins in schizophrenia
    Joober, R
    Benkelfat, C
    Jannatipour, M
    Turecki, G
    Lal, S
    Mandel, JL
    Bloom, D
    Lalonde, P
    Lopes-Cendes, I
    Fortin, D
    Rouleau, G
    MOLECULAR PSYCHIATRY, 1999, 4 (01) : 53 - 57
  • [2] Polyglutamine-containing proteins in schizophrenia
    R Joober
    C Benkelfat
    M Jannatipour
    G Turecki
    S Lal
    J-L Mandel
    D Bloom
    P Lalonde
    I Lopes-Cendes
    D Fortin
    G Rouleau
    Molecular Psychiatry, 1999, 4 : 53 - 57
  • [3] Prion-like properties of polyglutamine amyloids
    Kopito, R.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2010, 88 (02): : 413 - 413
  • [4] The fatal attraction of polyglutamine-containing proteins
    Hackam, AS
    Wellington, CL
    Hayden, MR
    CLINICAL GENETICS, 1998, 53 (04) : 233 - 242
  • [5] Prion and Prion-like Proteins
    Sano, Kazunori
    Hosokawa, Masato
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (07): : 987 - 987
  • [6] Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells?
    A Petronis
    J B Vincent
    L C Surh
    T Ashizawa
    J L Kennedy
    Molecular Psychiatry, 2000, 5 : 234 - 236
  • [7] Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells?
    Petronis, A
    Vincent, JB
    Surh, LC
    Ashizawa, T
    Kennedy, JL
    MOLECULAR PSYCHIATRY, 2000, 5 (03) : 234 - 236
  • [8] Prions and Prion-like Proteins
    Fraser, Paul E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (29) : 19839 - 19840
  • [9] Conservation of Prion-Like Composition and Sequence in Prion-Formers and Prion-Like Proteins of Saccharomyces cerevisiae
    Su, Ting-Yi
    Harrison, Paul M.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2019, 6
  • [10] Translational Control by Prion-like Proteins
    Li, Liying
    McGinnis, J. P.
    Si, Kausik
    TRENDS IN CELL BIOLOGY, 2018, 28 (06) : 494 - 505